-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS - EXPECTS Q2 2026 GAAP AND NON-GAAP NET INCOME PER DILUTED SHARE TO DECREASE BY $1 - SEC FILING

Reuters·07/06/2026 11:01:47

Please log in to view news